Review Article

Effects and Safety of Traditional Chinese Medicine for Hidden Blood Loss after Total Hip Arthroplasty—A Systematic Review and Meta-Analysis

Table 1

Characteristics of the 12 studies included in the meta-analysis.

StudySample size (IG/CG)Gender (Men/Women)Mean age or age rangeIntervention ProtocolDuration timeOutcomes
IGCGIGCGIGCG

Cai202036/36--69.03 ± 5.6470.39 ± 5.51Sanqi zhixue Decoction combined TXATXA7 days①②③④
Ji201915/156/96/969.73 ± 0.7970.87 ± 1.65Bazhen Decoction combined TXATXA14 days①②③
Ke201730/3011/1914/1671.1 ± 8.366.8 ± 10.1Taohong Siwu Decoction combined TXATXA7 days①②
Li202237/3426/1124/1077.2 ± 7.779.6 ± 9.3Yiqi Huoxue ointment combined TXATXA7 days①②③④
Ma201853/5424/2926/2871.99 ± 7.2972.03 ± 7.31Bazhen Decoction combined TXATXA14 days②③
Miao201762/6238/2441/2175.67 ± 8.3273.72 ± 7.83Fuyuan DecoctionTXA7 days②③
Qiu201830/3020/1022/864.25 ± 2.5664.23 ± 2.54Yunnan Baiyao combined TXATXA7 days①②④
Qiu201933/3419/1618/1769.13 ± 3.2668.62 ± 3.18Bazhen decoction combined TXATXA14 days①②③④
Sheng201720/206/147/1368.7 ± 5.3370.7 ± 4.68Addition of Shiquan Dabu DecoctionAnti-infection and anticoagulation14 days①②③
Wang201545/4522/2321/2466.0 ± 6.766.2 ± 6.5Tanshinone CapsulesLow molecular weight heparin7 days①②③⑤
Xiao202030/309/218/2265.6 ± 4.866.2 ± 5.2Sanqi zhixue DecoctionNo hemostatic drugs14 days①②③
Zhou201950/5020/3022/2852–7050–70Chuanxi San combined TXATXA30 days

CG: control group; IG: intervention group “-”: not mentioned ① TBL, ② HBL, ③ Hb, ④ HCT, ⑤ Incidence of Adverse Reactions.